Literature DB >> 2964984

Serum lipids, lipoproteins and macrovascular disease in non-insulin-dependent diabetics: a possible new approach to prevention.

P W Seviour1, T K Teal, W Richmond, R S Elkeles.   

Abstract

The relationship between macrovascular disease and serum lipids, low density lipoprotein (LDL) cholesterol, high density lipoprotein (HDL), and subfraction cholesterol, and apolipoproteins has been examined in 53 female and 95 male patients with non-insulin-dependent diabetes mellitus (NIDDM). In males, those with macrovascular disease had higher serum and LDL cholesterol concentrations than those without. In females, those with macrovascular disease had higher levels of serum triglyceride, cholesterol, LDL cholesterol, as well as lower HDL, HDL2, and HDL3 cholesterol and apoprotein A-1, than those without. On multivariate analysis, LDL cholesterol was the most important association with macrovascular disease in males and apoprotein A-1 in females. In a subgroup of 36 patients, a double-blind placebo controlled study using bezafibrate or placebo, in addition to conventional oral hypoglycaemic therapy over 4 months, showed falls in serum and LDL cholesterol and in serum triglyceride and a rise in HDL cholesterol in the treated group. These changes should reduce the incidence of macrovascular disease in NIDDM and we suggest further prospective studies of such therapy in addition to conventional oral hypoglycaemic agents.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2964984     DOI: 10.1111/j.1464-5491.1988.tb00965.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  9 in total

Review 1.  Effects of drugs on glucose tolerance in non-insulin-dependent diabetics (Part II).

Authors:  S O'Byrne; J Feely
Journal:  Drugs       Date:  1990-08       Impact factor: 9.546

Review 2.  Specific lipid lowering therapy in the management of diabetes.

Authors:  P N Durrington
Journal:  Postgrad Med J       Date:  1991-10       Impact factor: 2.401

Review 3.  Treatment of diabetes: the effect on serum lipids and lipoproteins.

Authors:  P K Merrin; R S Elkeles
Journal:  Postgrad Med J       Date:  1991-10       Impact factor: 2.401

Review 4.  Primary, secondary and tertiary prevention of non-insulin-dependent diabetes.

Authors:  A Dornhorst; P K Merrin
Journal:  Postgrad Med J       Date:  1994-08       Impact factor: 2.401

Review 5.  Bezafibrate. An update of its pharmacology and use in the management of dyslipidaemia.

Authors:  K L Goa; L B Barradell; G L Plosker
Journal:  Drugs       Date:  1996-11       Impact factor: 9.546

6.  The reduction of low density lipoprotein cholesterol by metformin is maintained with long-term therapy.

Authors:  S G Rains; G A Wilson; W Richmond; R S Elkeles
Journal:  J R Soc Med       Date:  1989-02       Impact factor: 5.344

Review 7.  Antihyperglycaemic agents. Drug interactions of clinical importance.

Authors:  A J Scheen; P J Lefèbvre
Journal:  Drug Saf       Date:  1995-01       Impact factor: 5.606

8.  Lipids in non-insulin dependent diabetes: a case for treatment?

Authors:  R S Elkeles
Journal:  J R Soc Med       Date:  1991-07       Impact factor: 18.000

9.  Alterations in lipid transfers to HDL associated with the presence of coronary artery disease in patients with type 2 diabetes mellitus.

Authors:  Marilia C O Sprandel; Whady A Hueb; Alexandre Segre; José A F Ramires; Roberto Kalil-Filho; Raul C Maranhão
Journal:  Cardiovasc Diabetol       Date:  2015-08-14       Impact factor: 9.951

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.